Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACE | P12821 | 2/20 | 0.79 |
| ▸ | CTSS | P25774 | 3/20 | 0.70 |
| ▸ | CTSK | P43235 | 2/20 | 0.70 |
| ▸ | CTSL | P07711 | 1/20 | 0.70 |
| ▸ | CTSB | P07858 | 1/20 | 0.70 |
| ▸ | PPARA | Q07869 | 5/20 | 0.64 |
| ▸ | PPARG | P37231 | 4/20 | 0.64 |
| ▸ | ITGB3 | P05106 | 1/20 | 0.62 |
| ▸ | ITGA2B | P08514 | 1/20 | 0.62 |
| ▸ | APP | P05067 | 1/20 | 0.62 |
| ▸ | ATM | Q13315 | 2/20 | 0.61 |
| ▸ | AKT1 | P31749 | 1/20 | 0.60 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.60 |
| ▸ | PPARD | Q03181 | 2/20 | 0.58 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.58 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.58 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL606309 | 1.00 | ACE (0.79) | ACECTSSCTSKCTSLCTSB | |
| SCHEMBL27909397 | 1.00 | ACE (0.79) | ACECTSSCTSKCTSLCTSB | |
| SCHEMBL21473784 | 1.00 | ACE (0.79) | ACECTSSCTSKCTSLCTSB | |
| SCHEMBL67020 | 1.00 | ACE (0.79) | ACECTSSCTSKCTSLCTSB | |
| SCHEMBL66220 | 1.00 | ACE (0.79) | ACECTSSCTSKCTSLCTSB | |
| SCHEMBL29707278 | 0.98 | ACE (0.77) | ACECTSSCTSKCTSLCTSB | |
| Water SCHEMBL15362012 | 0.98 | ACE (0.77) | ACECTSSCTSKCTSLCTSB | |
| Water SCHEMBL15362013 | 0.98 | ACE (0.77) | ACECTSSCTSKCTSLCTSB | |
| SCHEMBL26654474 | 0.98 | ACE (0.77) | ACECTSSCTSKCTSLCTSB | |
| SCHEMBL26654472 | 0.98 | ACE (0.77) | ACECTSSCTSKCTSLCTSB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20160354346-A1 | ESTER PRO-DRUGS OF [3-(1-(1H-IMIDAZOL-4-YL)ETHYL)-2-METHYLPHENYL] METHANOL FOR TREATING SKIN DISEASES AND CONDITIONS | ALLERGAN, INC. | 2016-12-08 | — | — | US | disclosed |
| US-20150148394-A1 | ESTER PRO-DRUGS OF [3-(1-(1H-IMIDAZOL-4-YL)ETHYL)-2-METHYLPHENYL] METHANOL FOR TREATING SKIN DISEASES AND CONDITIONS | ALLERGAN INC (US) | 2015-05-28 | — | — | US | disclosed |
| US-8853251-B2 | Ester pro-drugs of [3-(1-(1H-imidazol-4-YL)ethyl)-2-methylphenyl] methanol for treating retinal diseases | ALLERGAN, INC. (US) | 2014-10-07 | — | — | US | disclosed |
| US-20140057958-A1 | ESTER PRO-DRUGS OF [3-(1-(1H-IMIDAZOL-4-YL)ETHYL)-2-METHYLPHENYL] METHANOL FOR TREATING RETINAL DISEASES | ALLERGAN, INC. (US) | 2014-02-27 | — | — | US | disclosed |
| US-8653123-B2 | Ester pro-drugs of [3-(1-(1H-imidazol-4-yl)ethyl)-2-methylphenyl] methanol for treating retinal diseases | ALLERGAN, INC. (US) | 2014-02-18 | — | — | US | disclosed |
| US-20130296394-A1 | ESTER PRO-DRUGS OF [3-(1-(1H-IMIDAZOL-4-YL)ETHYL)-2-METHYLPHENYL] METHANOL FOR TREATING SKIN DISEASES AND CONDITIONS | ALLERGAN, INC. (US) | 2013-11-07 | — | — | US | disclosed |
| US-20130289088-A1 | ESTER PRO-DRUGS OF [3-(1-(1H-IMIDAZOL-4-YL)ETHYL)-2-METHYLPHENYL] METHANOL FOR LOWERING INTRAOCULAR PRESSURE | ALLERGAN INC (US) | 2013-10-31 | — | — | US | disclosed |
| EP-2616069-A1 | ESTER PRO-DRUGS OF [3-(1-(1H-IMIDAZOL-4-YL)ETHYL)-2-METHYLPHENYL]METHANOL | Allergan, Inc. (US) | 2013-07-24 | — | — | EP | disclosed |
| EP-2616067-A1 | ESTER PRO-DRUGS OF [3-(1-(1H-IMIDAZOL-4-YL)ETHYL)-2-METHYLPHENYL]METHANOL FOR TREATING SKIN DISEASES AND CONDITIONS | Allergan, Inc. (US) | 2013-07-24 | — | — | EP | disclosed |
| EP-2616068-A1 | ESTER PRO-DRUGS OF [3-(1-(1H-IMIDAZOL-4-YL)ETHYL)-2-METHYLPHENYL]METHANOL FOR LOWERING INTRAOCULAR PRESSURE | Allergan, Inc. (US) | 2013-07-24 | — | — | EP | disclosed |
| US-20120149746-A1 | ESTER PRO-DRUGS OF [3-(1-(1H-IMIDAZOL-4-YL)ETHYL)-2-METHYLPHENYL] METHANOL FOR TREATING RETINAL DISEASES | ALLERGAN, INC. (US) | 2012-06-14 | — | — | US | disclosed |
| US-20120142746-A1 | ESTER PRO-DRUGS OF [3-(1-(1H-IMIDAZOL-4-YL)ETHYL)-2-METHYLPHENYL] METHANOL FOR LOWERING INTRAOCULAR PRESSURE | ALLERGAN, INC. (US) | 2012-06-07 | — | — | US | disclosed |
| US-20120136036-A1 | ESTER PRO-DRUGS OF [3-(1-(1H-IMIDAZOL-4-YL)ETHYL)-2-METHYLPHENYL] METHANOL FOR TREATING SKIN DISEASES AND CONDITIONS | ALLERGAN, INC. (US) | 2012-05-31 | — | — | US | disclosed |
| US-20120122945-A1 | ESTER PRO-DRUGS OF [3-(1-(1H-IMIDAZOL-4-YL)ETHYL)-2-METHYLPHENYL] METHANOL | ALLERGAN, INC. (US) | 2012-05-17 | — | — | US | disclosed |
| WO-2012037499-A1 | ESTER PRO-DRUGS OF [3-(1-(1H-IMIDAZOL-4-YL)ETHYL)-2-METHYLPHENYL] METHANOL | ALLERGAN, INC. (US) | 2012-03-22 | — | — | WO | disclosed |
| WO-2012037484-A1 | ESTER PRO-DRUGS OF [3-(1-(1H-IMIDAZOL-4-YL)ETHYL)-2-METHYLPHENYL] METHANOL FOR TREATING SKIN DISEASES AND CONDITIONS | ALLERGAN, INC. (US) | 2012-03-22 | — | — | WO | disclosed |
| WO-2012037490-A1 | ESTER PRO-DRUGS OF [3-(1-(1H-IMIDAZOL-4-YL)ETHYL)-2-METHYLPHENYL] METHANOL FOR LOWERING INTRAOCULAR PRESSURE | ALLERGAN, INC. (US) | 2012-03-22 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (9 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160354346-A1 | ESTER PRO-DRUGS OF [3-(1-(1H-IMIDAZOL-4-YL)ETHYL)-2-METHYLPHENYL] METHANOL FOR TREATING SKIN DISEASES AND CONDITIONS | TYR, EBP, CUTA | ACE 862/4885CTSS 1989/4885CTSK 1072/4885 |
| US-20130289088-A1 | ESTER PRO-DRUGS OF [3-(1-(1H-IMIDAZOL-4-YL)ETHYL)-2-METHYLPHENYL] METHANOL FOR LOWERING INTRAOCULAR PRESSURE | REN, CYP11B2, PDE3A | ACE 52/4885CTSS 3613/4885CTSK 1774/4885 |
| US-20140057958-A1 | ESTER PRO-DRUGS OF [3-(1-(1H-IMIDAZOL-4-YL)ETHYL)-2-METHYLPHENYL] METHANOL FOR TREATING RETINAL DISEASES | PDE6D, ALDH1A2, PDE6A | ACE 1093/4885CTSS 2888/4885CTSK 1702/4885 |
| US-20120142746-A1 | ESTER PRO-DRUGS OF [3-(1-(1H-IMIDAZOL-4-YL)ETHYL)-2-METHYLPHENYL] METHANOL FOR LOWERING INTRAOCULAR PRESSURE | REN, CYP11B2, PDE3A | ACE 52/4885CTSS 3613/4885CTSK 1774/4885 |
| US-20120136036-A1 | ESTER PRO-DRUGS OF [3-(1-(1H-IMIDAZOL-4-YL)ETHYL)-2-METHYLPHENYL] METHANOL FOR TREATING SKIN DISEASES AND CONDITIONS | TYR, EBP, CUTA | ACE 862/4885CTSS 1989/4885CTSK 1072/4885 |
| US-20130296394-A1 | ESTER PRO-DRUGS OF [3-(1-(1H-IMIDAZOL-4-YL)ETHYL)-2-METHYLPHENYL] METHANOL FOR TREATING SKIN DISEASES AND CONDITIONS | TYR, EBP, CUTA | ACE 862/4885CTSS 1989/4885CTSK 1072/4885 |
| US-20150148394-A1 | ESTER PRO-DRUGS OF [3-(1-(1H-IMIDAZOL-4-YL)ETHYL)-2-METHYLPHENYL] METHANOL FOR TREATING SKIN DISEASES AND CONDITIONS | TYR, EBP, CUTA | ACE 862/4885CTSS 1989/4885CTSK 1072/4885 |
| US-20120149746-A1 | ESTER PRO-DRUGS OF [3-(1-(1H-IMIDAZOL-4-YL)ETHYL)-2-METHYLPHENYL] METHANOL FOR TREATING RETINAL DISEASES | PDE6D, ALDH1A2, PDE6A | ACE 1093/4885CTSS 2888/4885CTSK 1702/4885 |
| US-20120122945-A1 | ESTER PRO-DRUGS OF [3-(1-(1H-IMIDAZOL-4-YL)ETHYL)-2-METHYLPHENYL] METHANOL | ADRB3, ADRB1, ADRB2 | ACE 317/4885CTSS 2554/4885CTSK 2314/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.